ÂÜÀòÂÒÂ×

Erika Mariotti is a highly experienced professional in biomedical engineering and digital innovation, currently serving as Device Innovation Lead and Digital Strategy and Portfolio Manager at Boehringer Ingelheim since November 2020. Prior roles include Head of Development at NEO New Oncology AG, where leadership of interdisciplinary teams was pivotal in product development, and Head of Computational Biology, focusing on bioinformatic pipeline optimization and CE certification. Erika's earlier experience encompasses senior computational biology roles and postdoctoral research at reputable institutions, including the University of Cologne and King's College London, contributing significantly to pharmacokinetic modeling and bioinformatic software development. Erika holds a Master's degree and Bachelor's degree in Biomedical/Medical Engineering from the University of Rome "Tor Vergata."